Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Thermo Fisher Scientific Inc (TMO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Thermo Fisher Scientific's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
567.30 -5.27    -0.92%
29/05 - Closed. Currency in USD ( Disclaimer )
Pre Market
556.00
-11.30
-1.99%
8:45:43 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,321,793
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 563.67 - 569.91
Thermo Fisher Scientific 567.30 -5.27 -0.92%

TMO Income Statement

 
Featured here, the Income Statement (earnings report) for Thermo Fisher Scientific Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
30/03
2023
31/12
2023
30/09
2023
01/07
Total Revenue 10345 10886 10574 10687
Revenue 10345 10886 10574 10687
Other Revenue, Total - - - -
Cost of Revenue, Total 6025 6490 6253 6429
Gross Profit 4320 4396 4321 4258
Total Operating Expenses 8619 8855 8625 8923
Selling/General/Admin. Expenses, Total 1712 2037 2053 2149
Research & Development 331 327 319 345
Depreciation / Amortization 286 1068 - 1129
Interest Expense (Income) - Net Operating -363 -390 -359 -311
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 628 391 359 311
Operating Income 1726 2031 1949 1764
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 10 -21 16 -
Other, Net 103 313 185 350
Net Income Before Taxes 1613 1739 1748 1414
Provision for Income Taxes 281 133 53 52
Net Income After Taxes 1332 1606 1695 1362
Minority Interest 119 107 136 163
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1328 1630 1715 1361
Total Extraordinary Items - - - -
Net Income 1328 1630 1715 1361
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1328 1630 1715 1361
Dilution Adjustment -0.64 0.4 0.04 -0.88
Diluted Net Income 1328.64 1629.6 1714.96 1361.88
Diluted Weighted Average Shares 384 388 388 388
Diluted EPS Excluding Extraordinary Items 3.46 4.2 4.42 3.51
DPS - Common Stock Primary Issue 0.39 0.35 0.35 0.35
Diluted Normalized EPS 2.7 3.16 2.99 2.57
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TMO Comments

Write your thoughts about Thermo Fisher Scientific Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Franjo Tahi
Franjo Tahi Oct 25, 2023 11:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why not 200% up ?
Ashraf Mahmoud
Ashraf Mahmoud Jul 28, 2022 8:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
30% up
Ashraf Mahmoud
Ashraf Mahmoud May 20, 2022 3:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
20% up next week
David Lousada
David Lousada Dec 06, 2021 11:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why falling ao hard today?
Yung Money
Yung Money Oct 27, 2021 2:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
does this thermo site pay 💵💴
nn st
nn st Jun 02, 2021 11:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good news for TMO,, moderna :announces agreement with TMO for finish manufacturing of moderna covid 19 vaccine
Jun 02, 2021 11:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A Valid reason for going down
Makoto Kondo
Makoto Kondo Jun 01, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened??
EEKKNNDD WW
EEKKNNDD WW Jun 01, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Musn here we go?129?
Alvar Esteban
Alvar Esteban Jan 12, 2021 4:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You North Americans do not use this web/app for forums communications... where is people? Where takes place the stock market discussion?
Minna Andreasen
Minna Andreasen Jan 12, 2021 4:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Twitter etc
Jan 12, 2021 4:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Let's discuss bro
Duane Goodson
Duane Goodson Jan 05, 2021 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
RDGL approval or denial by Jan 16 by the FDA for breakthrough designation for their tumor fighting drug
Info Buffet
Info Buffet Dec 30, 2020 2:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Needham analyst Stephen Unger reiterated a Buy rating on Thermo Fisher on Wednesday, setting a price target of $539
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email